USPTO serial 90767113
Serial No. 90767113
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, REBECCA A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 90767113?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexandra Kochian
Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 W 42nd St, 17th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines | ACTIVE | — |
| 042 | Scientific research in the fields of pharmaceuticals, medicines, biologics, therapeutics, biotherapeutics, biosimilars, and therapeutic and prophylactic vaccines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 15, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 30, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 18, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 17, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 15, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 15, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 17, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 17, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 10, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 10, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 10, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 26, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 11, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 7, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 7, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 9, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 7, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 7, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 17, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 14, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 12, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 5, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 5, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 16, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 31, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2021 | NWAP | NEW APPLICATION ENTERED | — |